Skip to main content

Table 1 Relation between short-term response across different treatments after BMs (n = 113)

From: Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases

 

Response

P

Complete

Partial

Stable

Progressive

Objective response rate

Treatment

n

Response

Response

Disease

Disease

None

18

0

0

9 (50.0%)

9 (50.0%)

0

< 0.05

Chemotherapy

15

0

4 (26.7%)

6 (40.0%)

5 (33.3%)

4 (26.7%)

Radiotherapy

27

5 (18.5%)

12 (44.4%)

6 (22.2%)

4 (14.8%)

17 (63.0%)

Targeted

14

1 (7.1%)

6 (42.9%)

5 (35.7%)

2 (14.3%)

7 (50.0%)

Targeted combined radiotherapy

39

13 (33.3%)

22 (56.4%)

3 (7.7%)

1 (2.6%)

35 (89.7%)